PRA Health Sciences prête à satisfaire les exigences du RACE Act pour l’oncologie pédiatrique

    NEXT STORY
    CB2 Insights Announces Record Annual Revenue of $13.4 million for FY 2019 Sequential Growth of 25%
    PREV STORY
    BeyondSpring Announces Proposed Public Offering of Ordinary Shares
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    BeyondSpring Reports Fourth-Quarter and Full-Year 2019 Financial Results and Operational Update

    author_avatar
    NASDAQ Market News

    Iovance Biotherapeutics Reports Second Quarter 2017 Financial Results

    SAN CARLOS, Calif., Aug. 01, 2017 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a ...

    author_avatar
    NASDAQ Market News

    Aptevo Therapeutics Augments Leadership Team

    Appoints Former GlaxoSmithKline Executive Randy Maddux Senior Vice President, Operations Jane Gross, Ph.D., Promoted to ...

    author_avatar
    NASDAQ Market News